Conduit Pharmaceuticals Files Current Report
Ticker: CDTTW · Form: 8-K · Filed: Mar 6, 2025 · CIK: 1896212
| Field | Detail |
|---|---|
| Company | Conduit Pharmaceuticals Inc. (CDTTW) |
| Form Type | 8-K |
| Filed Date | Mar 6, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, SEC Filing, Corporate Update
TL;DR
Conduit Pharma filed an 8-K, check for updates.
AI Summary
Conduit Pharmaceuticals Inc. filed an 8-K on March 6, 2025, reporting an event on March 5, 2025. The company, formerly known as Murphy Canyon Acquisition Corp. until November 30, 2021, is incorporated in Delaware and has its principal executive offices in Naples, Florida. The filing indicates it is a "Current Report" under Section 13 or 15(d) of the Securities Exchange Act of 1934.
Why It Matters
This filing indicates Conduit Pharmaceuticals Inc. is providing an update to the SEC, which could contain material information relevant to investors.
Risk Assessment
Risk Level: low — This is a routine filing and does not appear to contain significant negative or positive news on its own.
Key Numbers
- 001-41245 — SEC File Number (Identifies the company's filing history with the SEC.)
- 87-3272543 — IRS Employer Identification No. (Company's tax identification number.)
Key Players & Entities
- Conduit Pharmaceuticals Inc. (company) — Registrant
- Murphy Canyon Acquisition Corp. (company) — Former company name
- November 30, 2021 (date) — Date of name change
- March 5, 2025 (date) — Earliest event reported
- March 6, 2025 (date) — Date of report filing
FAQ
What specific event triggered this 8-K filing?
The filing states it is a 'Current Report' pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934, with the earliest event reported on March 5, 2025. However, the specific nature of the event is not detailed in the provided text.
What was Conduit Pharmaceuticals Inc. previously named?
Conduit Pharmaceuticals Inc. was formerly known as Murphy Canyon Acquisition Corp. until November 30, 2021.
In which state is Conduit Pharmaceuticals Inc. incorporated?
Conduit Pharmaceuticals Inc. is incorporated in Delaware.
Where are Conduit Pharmaceuticals Inc.'s principal executive offices located?
Conduit Pharmaceuticals Inc.'s principal executive offices are located at 4851 Tamiami Trail North, Suite 200, Naples, FL 34103.
What is the SIC code for Conduit Pharmaceuticals Inc.?
The Standard Industrial Classification (SIC) code for Conduit Pharmaceuticals Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 6, 2025 regarding CONDUIT PHARMACEUTICALS INC. (CDTTW).